SOURCE |
SOURCE |
Fluid Compartment Measurement:
1) plasma volume = radiolabeled albumin
2) ECF = inulin
Ux = urine concentration of X
Px = plasma concentration of X
V = urine flow rate
"Tracers used fall into 2 groups:
3) Interstitial Fluid (no tracer) = ECF - Plasma Volume
4) Intracellular Fluid (no tracer) = Total body water - ECF
Is potassium higher intracellular or extracellularly?
HIKIN': HIigh K INintracellular
SOURCE |
Glomerular Filtration Barrier (3 layers)
1) fenestrated capillary endothelium
2) Fused glomerular basement membrane with heparan sulfate (negative charge barrier)
3) Epithelial layer w/ podocytes foot process and slit diaphragms
source |
source |
What happens to the glomerular filtration barrier in nephrotic syndrome?
the charge barrier is lost --> albuminuria, hypoproteinemia, generalized edema, hyperlipidemia
Renal Clearance and Glomerular Filtration Rate:
------------------------
Px
This is the volume of plasma from which the substance is completed cleared per unit time.
Cx = clearance of X in mL/minUx = urine concentration of X
Px = plasma concentration of X
V = urine flow rate
GFR does not equate excretion but only filtration. Therefore, if GFR is greater than clearance there is a net reabsorption of a substance.
source |
source |
What do incremental reductions in GFR denote? stages of chronic kidney disease
Effective Renal Plasma Flow
Effective renal plasma flow (ERPF) = U_pah x V/ Ppah = Cpah
source |
Renal Blood Flow = RPF/ (1-HCT)
Clinical Relevance for Glucosuria: Diabetes Mellitus
Determinants of Glomerular Filtration Rate (GFR)
Explain why a decrease in plasma protein concentration causes an increase in GFR?
The primary driving force for GFR is blood pressure opposed by fluid pressure in Bowman's capsule and colloid osmotic pressure due to plasma proteins. With fewer plasma proteins, the plasma has lower than normal colloid osmotic pressure. With less colloid osmotic pressure opposing GFR, GFR increases.
Calculation of reabsorption and secretion rate
source source |
Filtered load = GFR X Px
Excretion rate = V X Ux
Reabsorption = filtered - excreted
Secretion = excreted - filtered
Glucose Clearance
source
Filtration Fraction (FF) = GFR/RPF
Filtered Load = GFR x plasma concentration
What is affected in renal artery stenosis? the afferent artery; renal artery stenosis decreases GFR and FF. Plasma protein concentration relationship with RPF, GFR, and FF.
Plasma protein concentration does not affect renal plasma flow. RPF is only changed by afferent/efferent arteriole constriction/dilatation. However increased plasma protein increases plasma oncotic pressure, leading to a decreased filtration fraction. Thus GFR is decreased but RPF is constant. Therefore, there is a decrease overall Filtration Fraction (GFR/RPF).
Glucose Clearance
|
source source SGLT2: High Capacity Low Affinity SGLT1: Low Capacity High Affinity
Glucosuria: the excretion of glucose into the urine. Ordinarily, urine contains no glucose because the kidneys are able to reclaim all of the filtered glucose back into the bloodstream.
|
~ 160 mg/dL of plasma glucose, glucosuria begins 350 mg/dL, transporters are saturated (Tm) |
source |
Amino Acid Clearance
source |
source Sodium Dependent Transporters in PCT reabsorb amino acids. |
Clinical Relevance: Hartnup's Disease = an autosomal recessive defect results from impaired transport of neutral amino acids across (i.e. tryptophan) epithelial cells in renal proximal tubules and intestinal mucosa. Symptoms include transient manifestations of pellagra (rashes), cerebellar ataxia and psychosis.
source |
I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
ReplyDeleteliver already present. I started on antiviral medications which
reduced the viral load initially. After a couple of years the virus
became resistant. I started on HEPATITIS B Herbal treatment from
ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
treatment totally reversed the virus. I did another blood test after
the 6 months long treatment and tested negative to the virus. Amazing
treatment! This treatment is a breakthrough for all HBV carriers.